Page last updated: 2024-08-17

ficusin and 5-(4-phenylbutoxy)psoralen

ficusin has been researched along with 5-(4-phenylbutoxy)psoralen in 20 studies

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (15.00)29.6817
2010's14 (70.00)24.3611
2020's3 (15.00)2.80

Authors

AuthorsStudies
Bode, CW; Hänsel, W1
Ansari, AA; Pereira, LE; Raman, G; Sankaranarayanan, A; Villinger, F; Wulff, H1
Bhat, MA; Garg, P; Koulen, P; Stokely, ME1
Fujinaka, H; Higashi, K; Hokari, R; Hyodo, T; Kikuchi, Y; Kinoshita, M; Kumagai, H; Kushiyama, T; Miura, S; Oda, T; Seki, S; Suzuki, S; Yamada, M; Yamamoto, K; Yamamoto, T1
Beech, DJ; Cheong, A; Kumar, B; Li, J; Munsch, C; Porter, KE; Riches, K; Sukumar, P; Wood, IC; Zeng, F1
Chen, ZW; Hao, B; Miljanich, GP; Wang, YX; Wulff, H; Zhou, XJ; Zimin, PI1
Buxton, JM; Cosgrove, P; Coughlan, KA; Jackson, VM; Kreeger, JM; Perez, SM; Straub, SV; Tan, B; Trebino, CE1
Cao, M; He, W; Lü, C; Quan, X; Ruan, L; Wang, X; Wu, X; Xu, R; Zhang, C1
Chandy, KG; Gulbins, E; Henry, B; Leanza, L; Sassi, N; Szabò, I; Zoratti, M1
Becker, KA; Frezzato, F; Gulbins, E; Leanza, L; Semenzato, G; Szabo, I; Trentin, L; Zoratti, M1
Abbruzzese, JL; Baukrowitz, T; Decher, N; Marzian, S; Nematian-Ardestani, E; Rapedius, M; Rinné, S; Sanguinetti, MC; Sansom, MS; Stansfeld, PJ; Steinmeyer, K1
Ashford, ML; Beall, C; Chevtzoff, C; Cuthbertson, DJ; Hamilton, DL; Jeromson, S1
Imura, K; Kasai-Yamamoto, E; Nagira, M; Shichijo, M; Tai, N; Ueyama, A; Yasui, K1
He, SW; Hou, GQ; Jiang, S; Li, ZY; Qiu, YT; Xiao, Z; Xu, HJ; Zheng, H; Zhou, YY1
Di Lucente, J; Hilt, S; Jenkins, DP; Jin, LW; Kim, K; Levey, AI; Maezawa, I; Nguyen, HM; Rangaraju, S; Singh, V; Wulff, H1
Admasu, TD; Barardo, D; Cazenave-Gassiot, A; Chaithanya Batchu, K; Gruber, J; Lam, VYM; Ng, LF; Tolwinski, NS; Wenk, MR; Xiao, L1
Ding, S; Fang, C; Hu, J; Liu, X; Mei, Q; Mei, Y; Xu, J1
Cao, Z; Cheng, Y; Gao, M; Hu, J; Ji, Z; Lang, Y; Li, F; Liu, Q; Shen, B; Sun, F; Wu, Y; Xia, Z; Xie, C; Yao, J; Yi, W1
Admasu, TD; Barardo, D; Batchu, KC; Cazenave-Gassiot, A; Gruber, J; Ng, LF; Wenk, MR1
Chen, YJ; Cui, Y; Singh, L; Wulff, H1

Other Studies

20 other study(ies) available for ficusin and 5-(4-phenylbutoxy)psoralen

ArticleYear
5-(3-Phenylpropoxy)psoralen and 5-(4-phenylbutoxy)psoralen: mechanistic studies on phototoxicity.
    Die Pharmazie, 2005, Volume: 60, Issue:3

    Topics: Animals; Cross-Linking Reagents; Dermatitis, Phototoxic; DNA; Erythrocytes; Ficusin; Free Radicals; Hemolysis; In Vitro Techniques; Kv1.3 Potassium Channel; Lipids; Oxidation-Reduction; Oxygen; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Proteins; Spectrophotometry, Ultraviolet; Superoxides; Swine; Ultraviolet Rays

2005
Pharmacokinetics, toxicity, and functional studies of the selective Kv1.3 channel blocker 5-(4-phenoxybutoxy)psoralen in rhesus macaques.
    Experimental biology and medicine (Maywood, N.J.), 2007, Volume: 232, Issue:10

    Topics: Animals; Antibody Formation; Electrophysiology; Ficusin; Immunity, Cellular; Immunologic Memory; Kv1.3 Potassium Channel; Macaca mulatta; Pancreatitis-Associated Proteins; T-Lymphocytes

2007
Transient 5-(4-phenylbutoxy)psoralen (PAP-1) treatment dissociates developing pathologies in autoimmune optic neuritis into two distinct pathology profiles.
    Journal of neuroscience research, 2008, Volume: 86, Issue:9

    Topics: Animals; Autoimmune Diseases; Endothelin-1; Female; Ficusin; Inflammation; Interleukin-1; Myelin Proteins; Myelin-Associated Glycoprotein; Myelin-Oligodendrocyte Glycoprotein; Optic Neuritis; Pancreatitis-Associated Proteins; Rats; Rats, Inbred BN

2008
Voltage-gated potassium channel Kv1.3 blocker as a potential treatment for rat anti-glomerular basement membrane glomerulonephritis.
    American journal of physiology. Renal physiology, 2010, Volume: 299, Issue:6

    Topics: Animals; Autoantibodies; Basement Membrane; CD8-Positive T-Lymphocytes; Cytokines; Ficusin; Glomerulonephritis; Kidney Glomerulus; Kv1.3 Potassium Channel; Rats; Rats, Inbred WKY; T-Lymphocytes

2010
Potent suppression of vascular smooth muscle cell migration and human neointimal hyperplasia by KV1.3 channel blockers.
    Cardiovascular research, 2011, Feb-01, Volume: 89, Issue:2

    Topics: Animals; Aorta, Thoracic; Calcium; Cell Movement; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Ficusin; Humans; Hyperplasia; Immunohistochemistry; Kv1.3 Potassium Channel; Male; Membrane Potentials; Mice; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Organ Culture Techniques; Patch-Clamp Techniques; Potassium Channel Blockers; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Saphenous Vein; Scorpion Venoms; Time Factors; Triterpenes; Tunica Intima

2011
Identification of phase-I metabolites and chronic toxicity study of the Kv1.3 blocker PAP-1 (5-(4-phenoxybutoxy)psoralen) in the rat.
    Xenobiotica; the fate of foreign compounds in biological systems, 2011, Volume: 41, Issue:3

    Topics: Animals; Bile; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Feces; Ficusin; Kv1.3 Potassium Channel; Male; Metabolic Detoxication, Phase I; Microsomes, Liver; Pancreatitis-Associated Proteins; Potassium Channel Blockers; Rats; Rats, Sprague-Dawley; Toxicity Tests, Chronic

2011
Pharmacological inhibition of Kv1.3 fails to modulate insulin sensitivity in diabetic mice or human insulin-sensitive tissues.
    American journal of physiology. Endocrinology and metabolism, 2011, Volume: 301, Issue:2

    Topics: 3T3-L1 Cells; Adipose Tissue; Animals; CHO Cells; Cricetinae; Cricetulus; Diabetes Mellitus, Experimental; Ficusin; Glucose; Humans; Hyperglycemia; Insulin; Insulin Resistance; Kv1.3 Potassium Channel; Mice; Muscle, Skeletal; Obesity; Pancreatitis-Associated Proteins; Patch-Clamp Techniques; Potassium; Scorpion Venoms

2011
Kv1.3 channels as a potential target for immunomodulation of CD4+ CD28null T cells in patients with acute coronary syndrome.
    Clinical immunology (Orlando, Fla.), 2012, Volume: 142, Issue:2

    Topics: Acute Coronary Syndrome; Aged; Case-Control Studies; CD28 Antigens; CD4-Positive T-Lymphocytes; Female; Ficusin; Humans; Immunomodulation; Interferon-gamma; Kv1.3 Potassium Channel; Male; Middle Aged; Pancreatitis-Associated Proteins; Perforin; Potassium Channels, Calcium-Activated; T-Lymphocyte Subsets

2012
Inhibitors of mitochondrial Kv1.3 channels induce Bax/Bak-independent death of cancer cells.
    EMBO molecular medicine, 2012, Volume: 4, Issue:7

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; Cells, Cultured; Clofazimine; Down-Regulation; Ficusin; Humans; Jurkat Cells; Kv1.3 Potassium Channel; Melanoma, Experimental; Mice; Mitochondria; Pancreatitis-Associated Proteins; Potassium Channel Blockers; RNA Interference; RNA, Small Interfering; Signal Transduction

2012
Clofazimine, Psora-4 and PAP-1, inhibitors of the potassium channel Kv1.3, as a new and selective therapeutic strategy in chronic lymphocytic leukemia.
    Leukemia, 2013, Volume: 27, Issue:8

    Topics: Clofazimine; Ficusin; Humans; Kv1.3 Potassium Channel; Leukemia, Lymphocytic, Chronic, B-Cell; Pancreatitis-Associated Proteins; Potassium Channel Blockers

2013
Side pockets provide the basis for a new mechanism of Kv channel-specific inhibition.
    Nature chemical biology, 2013, Volume: 9, Issue:8

    Topics: Ficusin; Kv1.5 Potassium Channel; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Substrate Specificity

2013
Kv1.3 inhibitors have differential effects on glucose uptake and AMPK activity in skeletal muscle cell lines and mouse ex vivo skeletal muscle.
    The journal of physiological sciences : JPS, 2014, Volume: 64, Issue:1

    Topics: AMP-Activated Protein Kinases; Animals; Biological Transport; Calcium; Cell Line; Ficusin; Glucose; In Vitro Techniques; Kv1.3 Potassium Channel; Mice; Mitochondria, Muscle; Models, Animal; Muscle Fibers, Skeletal; Muscle, Skeletal; Pancreatitis-Associated Proteins; Potassium Channel Blockers; Rats; Scorpion Venoms

2014
Kv1.3 blockers ameliorate allergic contact dermatitis by preferentially suppressing effector memory T cells in a rat model.
    Clinical and experimental dermatology, 2013, Volume: 38, Issue:8

    Topics: Animals; Cells, Cultured; Dermatitis, Allergic Contact; Disease Models, Animal; Ear; Female; Ficusin; Immunologic Memory; Interferon-gamma; Kv1.3 Potassium Channel; Lymph Nodes; Potassium Channel Blockers; Rats; T-Lymphocytes

2013
Psora-4, a Kv1.3 Blocker, Enhances Differentiation and Maturation in Neural Progenitor Cells.
    CNS neuroscience & therapeutics, 2015, Volume: 21, Issue:7

    Topics: Analysis of Variance; Animals; Brain; Cell Differentiation; Cell Proliferation; Cells, Cultured; Embryo, Mammalian; Ficusin; Glial Fibrillary Acidic Protein; Kv1.3 Potassium Channel; Membrane Potentials; Mice; Microtubule-Associated Proteins; Neural Stem Cells; Neurogenesis; Patch-Clamp Techniques; Potassium Channel Blockers; RNA, Small Interfering

2015
Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer's disease: preclinical proof of concept.
    Brain : a journal of neurology, 2018, 02-01, Volume: 141, Issue:2

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Animals, Newborn; Avoidance Learning; Cells, Cultured; Disease Models, Animal; Exploratory Behavior; Ficusin; Gene Expression Regulation; Kv1.3 Potassium Channel; Membrane Potentials; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microglia; Mutation; Peptide Fragments; Potassium Channel Blockers; Presenilin-1; Shab Potassium Channels

2018
Drug Synergy Slows Aging and Improves Healthspan through IGF and SREBP Lipid Signaling.
    Developmental cell, 2018, 10-08, Volume: 47, Issue:1

    Topics: Aging; Allantoin; Animals; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Drosophila melanogaster; Drug Synergism; Ficusin; Gene Expression Regulation; Gene Regulatory Networks; Insulin-Like Growth Factor I; Lipid Metabolism; Lipids; Longevity; Metformin; Rifampin; Signal Transduction; Sirolimus; Sterol Regulatory Element Binding Protein 1; Transcriptome; Transforming Growth Factor beta

2018
PAP-1 ameliorates DSS-induced colitis with involvement of NLRP3 inflammasome pathway.
    International immunopharmacology, 2019, Volume: 75

    Topics: Animals; Anti-Inflammatory Agents; Cells, Cultured; Colitis; Colon; Dextran Sulfate; Ficusin; Inflammasomes; Kv1.3 Potassium Channel; Macrophages; Male; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Potassium Channel Blockers; Signal Transduction

2019
The Kv1.3 ion channel acts as a host factor restricting viral entry.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2021, Volume: 35, Issue:2

    Topics: Animals; Chlorocebus aethiops; Dengue; Dengue Virus; Endosomes; Ficusin; HEK293 Cells; Hepacivirus; Hepatitis C; Humans; Hydrogen-Ion Concentration; Kv1.3 Potassium Channel; Mice; Mice, Inbred C57BL; Mice, Knockout; Respirovirus Infections; Sendai virus; Transfection; Vero Cells; Virus Internalization; Zika Virus; Zika Virus Infection

2021
A small-molecule Psora-4 acts as a caloric restriction mimetic to promote longevity in C. elegans.
    GeroScience, 2022, Volume: 44, Issue:2

    Topics: Animals; Caenorhabditis elegans; Caloric Restriction; Ficusin; Humans; Longevity

2022
The potassium channel Kv1.3 as a therapeutic target for immunocytoprotection after reperfusion.
    Annals of clinical and translational neurology, 2021, Volume: 8, Issue:10

    Topics: Age Factors; Animals; Combined Modality Therapy; Disease Models, Animal; Female; Ficusin; Infarction, Middle Cerebral Artery; Kv1.3 Potassium Channel; Male; Mice; Mice, Inbred C57BL; Reperfusion; Stroke

2021